Skip to main content

Why So Many Americans Aren't Getting COVID Boosters

Medically reviewed by Drugs.com.

By Cara Murez HealthDay Reporter

THURSDAY, Oct. 5, 2023 -- More than 80% of eligible Americans did not get a COVID-19 booster shot last fall. Now, a new study reveals the reasons for the hesitation.

Nearly 40% of survey participants said a prior COVID-19 infection factored into their decision to not get the booster. Another 31.5% were worried about side effects. And an additional 28% didn’t think a booster would provide extra protection, while 23% said it wouldn’t protect from the new coronavirus.

“Our results indicate that we have a lot more work to do in terms of educating the public and health care providers about the importance of staying up to date on COVID-19 boosters,” said first study author Elizabeth Jacobs. She is a professor of epidemiology at the Zuckerman College of Public Health at the University of Arizona Health Sciences, in Tucson.

This research was done through Arizona CoVHORT, which began in May 2020 to track the effect of COVID infection on Arizonans.

Researchers hope the results, published in the Oct. 6 issue of the journal Vaccine, will help encourage interventions to get more people vaccinated.

A variety of strategies may be needed to improve vaccination rates, as age, ethnicity and education affected reasons for hesitation, according to the study.

“Our results indicate that many people don’t know that a booster provides additional protection even if they have already been infected or that the effectiveness of prior boosters wanes over time due to new variants,” Jacobs said in a university news release. “So it’s important to get another booster as we head into the fall and winter.”

Sources

  • University of Arizona Health Sciences, news release, Oct. 2, 2023

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted October 2023

Further Support and Information on COVID-19

Read this next

Extended Course of Paxlovid Adds No Benefit for Those With Long COVID

FRIDAY, June 7, 2024 -- An extended course of the antiviral drug Paxlovid won’t ease a person’s Long COVID symptoms, a new study finds. People who took Paxlovid for...

FDA Panel OKs New COVID Vaccine for Fall

THURSDAY, June 6, 2024 -- A U.S. Food and Drug Administration advisory panel on Wednesday recommended updating the formula for COVID vaccines ahead of a fall campaign that will...

Long COVID's Toll Outlined in New Report

THURSDAY, June 6, 2024 -- Long COVID continues to plague millions of Americans as the health costs of the pandemic linger four years later, a new report warns. In a hefty...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.